Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1211235.RAqff0UWu19QqZEC_1-hlHLckfGBjP51EJjo4ehwmCj6A130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1211235.RAqff0UWu19QqZEC_1-hlHLckfGBjP51EJjo4ehwmCj6A130_assertion type Assertion NP1211235.RAqff0UWu19QqZEC_1-hlHLckfGBjP51EJjo4ehwmCj6A130_head.
- NP1211235.RAqff0UWu19QqZEC_1-hlHLckfGBjP51EJjo4ehwmCj6A130_assertion description "[Generated anti-NLGP antibody (primarily IgG2a) was tested for its anti-tumor activity in murine carcinoma (EC, CT-26), sarcoma (S180) and melanoma (B16Mel) tumor models.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1211235.RAqff0UWu19QqZEC_1-hlHLckfGBjP51EJjo4ehwmCj6A130_provenance.
- NP1211235.RAqff0UWu19QqZEC_1-hlHLckfGBjP51EJjo4ehwmCj6A130_assertion evidence source_evidence_literature NP1211235.RAqff0UWu19QqZEC_1-hlHLckfGBjP51EJjo4ehwmCj6A130_provenance.
- NP1211235.RAqff0UWu19QqZEC_1-hlHLckfGBjP51EJjo4ehwmCj6A130_assertion SIO_000772 25128841 NP1211235.RAqff0UWu19QqZEC_1-hlHLckfGBjP51EJjo4ehwmCj6A130_provenance.
- NP1211235.RAqff0UWu19QqZEC_1-hlHLckfGBjP51EJjo4ehwmCj6A130_assertion wasDerivedFrom befree-2016 NP1211235.RAqff0UWu19QqZEC_1-hlHLckfGBjP51EJjo4ehwmCj6A130_provenance.
- NP1211235.RAqff0UWu19QqZEC_1-hlHLckfGBjP51EJjo4ehwmCj6A130_assertion wasGeneratedBy ECO_0000203 NP1211235.RAqff0UWu19QqZEC_1-hlHLckfGBjP51EJjo4ehwmCj6A130_provenance.